News for Mylan N.V. (MYL)

PR NewswireDUBLIN, Feb. 26, 2025 YUPELRI® (revefenacin) US net sales, recognized by Viatris, reached an all-time high of $66.7 million in Q4 2024 and $238

PR NewswireDUBLIN, Ireland, Feb. 12, 2025 DUBLIN, Ireland, Feb. 12, 2025 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will report its fourth q

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could rise if growth continues in 2025.

White Falcon returned, net of fees, 5.5% for Q4 2024 and 14.4% for the full year. Click here to read the full fund letter.

Stocks Analysis by MarketBeat.com (Jea Yu) covering: Teva Pharma Industries Ltd ADR, Viatris Inc. Read MarketBeat.com (Jea Yu)'s latest article on Investing.com

Viatris fined in Morocco over merger notification, sources say

PR NewswireDUBLIN, Nov. 20, 2024 DUBLIN, Nov. 20, 2024 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) will participate in a Fireside Chat at the

The Cancer Cachexia Market Size sector reached a market value of USD 2.02 Billion in 2019. Future projections show a bright outlook, with a Compound Annual Growth Rate (CAGR) of 5% from 2019 to 2032…

Sickle Cell Disease Market Size Was Valued at USD 2.40 Billion in 2023, and is Projected to Reach USD 12.38 Billion by 2032, Growing at a CAGR of 20.00%...

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global Acute Respiratory...

According to Research by SNS Insider, The Antipsychotic Drugs Market is Expected to Grow at a CAGR of 6.53% Through 2032, Supported by Increasing...

Wearable Injectors Market size was valued at USD 7.65 billion in 2023 to USD 23.89 billion by 2031, growing at a CAGR of 15.29% in the forecast period...

The increase in emerging industries and the increasing investment in developing advanced technologies are opportunities for liver fibrosis market growth....

Autoinjectors are self-injectable devices that deliver drugs via subcutaneous or intramuscular ways. They are an essential class of medical devices. ...

As per Fortune Business Insights’ report, the idiopathic inflammatory myopathy treatment Market share sector attained a worth of USD 652.3 million in 2018. Forecasts indicate a promising path ahead…

The Global Graves’ Disease (Overactive Thyroid) Market Size was Valued at USD 390.8 Million in 2023 and the Worldwide Graves’ Disease (Overactive Thyroid)...

DOJ clears Viatris in generic drug antitrust probe

The Global Viscosupplementation Market Size was Valued at USD 4.20 Billion in 2023 and the Worldwide Viscosupplementation Market Size is Expected to Reach...

The global transdermal drug delivery systems market size and share are currently valued at USD 27.42 billion in 2023. It is anticipated to generate an...